Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
4.79
Aug 12 • 5:34 AM ET Dollar change-1.22 Percentage change(-20.30%)
Aug 11, 9:15 PMFocalTherics prices 8.425M ADS offering at $4.75 for approximately $40 million, grants 30-day option for 1.26M additional ADSs
Index
-
Market Cap
179.53M
Enterprise Value
192.31M
Income
-30.77M
Sales
74.14M
Book/sh
0.27
Cash/sh
0.40
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
289
IPO
Aug 01, 1997
P/E
-
Forward P/E
-
PEG
-
P/S
2.42
P/B
17.77
P/C
11.96
P/FCF
-
EV/EBITDA
-
EV/Sales
2.59
Quick Ratio
0.99
Current Ratio
1.34
Debt/Eq
2.75
LT Debt/Eq
1.98
Option/Short
Yes / Yes
EPS (ttm)
-0.82
EPS next Y
-0.65
EPS next Q
-0.22
EPS this Y
-7.66%
EPS next Y
24.52%
EPS next 5Y
19.54%
EPS past 3/5Y
-106.02% -63.72%
Sales past 3/5Y
6.90% 8.30%
EPS Y/Y TTM
-43.38%
Sales Y/Y TTM
-
EPS Q/Q
-22.15%
Sales Q/Q
25.28%
Insider Own
0.53%
Insider Trans
5.30%
Inst Own
39.37%
Inst Trans
-0.24%
ROA
-40.21%
ROE
-130.05%
ROIC
-102.40%
Gross Margin
44.64%
Oper. Margin
-34.67%
Profit Margin
-41.50%
SMA20
-19.15%
SMA50
-10.76%
SMA200
21.03%
Trades
Shs Outstand
37.48M
Shs Float
37.28M
52W High
6.40 -25.16%
52W Low
1.26 280.16%
Volatility
4.61% 4.15%
ATR (14)
0.32
RSI (14)
31.11
Beta
-0.03
Rel Volume
1.23
Avg Volume
47.78K
Volume
2,928
Perf Week
-21.35%
Perf Month
-11.54%
Perf Quarter
17.40%
Perf Half Y
4.13%
Perf YTD
45.59%
Perf Year
252.21%
Perf 3Y
-40.05%
Perf 5Y
-14.46%
Perf 10Y
57.57%
Prev Close
6.01
Price
4.79
Change %
-20.30%
Date Action Analyst Rating Change Price Target Change
Jul-17-26Initiated Mizuho Outperform $15
May-15-25Downgrade Piper Sandler Overweight → Neutral
Apr-04-25Downgrade Jefferies Buy → Hold $2
Nov-01-22Initiated Jefferies Buy $11
Apr-28-21Initiated Piper Sandler Overweight $13
Apr-15-20Initiated B. Riley FBR Buy $5.50
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-11-26 09:10PM
04:28PM
04:22PM
Jul-30-26 05:00PM
Jun-30-26 07:30AM
07:30AM Loading…
Jun-16-26 07:30AM
May-29-26 07:30AM
May-21-26 07:30AM
May-14-26 07:30AM
May-13-26 04:30PM
May-07-26 07:30AM
Apr-30-26 08:30AM
Apr-16-26 07:30AM
Mar-25-26 03:01PM
07:30AM
07:30AM Loading…
Mar-10-26 07:30AM
Mar-09-26 08:17AM
Mar-04-26 07:30AM
Feb-12-26 07:30AM
Jan-12-26 07:30AM
Dec-30-25 10:42AM
Dec-26-25 12:20PM
Dec-11-25 10:06AM
Nov-20-25 07:30AM
Nov-18-25 07:00AM
Nov-06-25 04:00PM
07:30AM
Nov-04-25 07:00AM
Oct-27-25 07:00AM
Oct-23-25 07:00AM
08:30AM Loading…
Oct-20-25 08:30AM
Oct-17-25 09:50AM
Sep-30-25 07:00AM
Sep-16-25 07:00AM
Sep-08-25 07:00AM
Aug-28-25 07:00AM
Aug-27-25 09:29AM
Aug-26-25 07:00AM
Aug-25-25 07:00AM
Aug-07-25 07:00AM
Jul-04-25 04:19AM
Jul-01-25 07:00AM
May-27-25 07:00AM
May-16-25 03:09AM
May-15-25 07:00AM
May-14-25 09:56AM
May-01-25 07:00AM
Apr-30-25 09:01AM
Apr-29-25 09:05AM
07:00AM
Apr-28-25 01:19PM
Apr-24-25 07:00AM
Apr-22-25 07:00AM
Mar-28-25 03:01AM
Mar-27-25 11:56AM
07:10AM
Mar-06-25 07:00AM
Mar-03-25 07:00AM
Feb-06-25 08:00AM
Jan-13-25 07:00AM
Jan-10-25 07:00AM
Jan-08-25 07:00AM
Dec-04-24 09:10AM
Dec-02-24 07:00AM
Nov-27-24 07:00AM
Nov-22-24 08:00AM
Nov-19-24 08:00AM
Nov-08-24 06:02AM
Nov-07-24 07:00AM
Nov-06-24 08:00AM
07:50AM
Oct-30-24 01:01AM
Oct-24-24 08:00AM
Oct-01-24 07:00AM
Sep-19-24 08:00AM
Aug-29-24 08:00AM
Aug-28-24 07:00AM
Aug-07-24 07:00AM
Aug-06-24 07:00AM
Jul-22-24 06:33AM
Jul-19-24 04:15PM
Jul-08-24 07:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-17-24 08:10AM
May-16-24 12:52PM
08:00AM
May-06-24 08:00AM
May-02-24 08:00AM
Apr-23-24 08:00AM
Mar-29-24 09:44AM
Mar-27-24 11:53AM
07:00AM
Mar-13-24 07:00AM
Mar-06-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 07:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 08:00AM
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
CEO & DirectorMr. Ryan Rhodes
Chief Financial OfficerMr. Kenneth Mobeck
Executive Vice President of Marketing & Product ManagementMr. Steven Annen
Chief Operating OfficerMr. Carre Emmanuel
Chief Accounting OfficerMr. Francois Dietsch
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVINE JOSHUADirectorMay 11 '26Buy4.2210,00042,20035,000May 13 06:03 AM